Use of cookies
Cookies help us to provide our services. By using our website you agree that we can use cookies. Read more about our Privacy Policy and visit the following link: Privacy Policy (only in German)
2018.07.31
Active substance: nusinersen
The marketing authorization holder, Biogen, informs of the occurrence of communicating hydrocephalus not related to meningitis or bleeding under treatment with Spinraza. Biogen informs on several measures that should be followed.
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN